A Phase II Study of QLS12010 Capsules in Adults With Moderate to Severe Atopic Dermatitis

NCT07344051 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

160

Enrollment

INDUSTRY

Sponsor class

Conditions

Moderate-to-severe Atopic Dermatitis

Interventions

DRUG: QLS12010
DRUG: Placebo

Sponsor

Qilu Pharmaceutical Co., Ltd.